Insider · CIK 0002124300
Afonso Adriano Jose Galimberti
Files at SCL (STEPAN CO). First filing -, latest -.
In brief
Afonso Adriano Jose Galimberti files SEC Form 4 as officer at SCL (STEPAN CO). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Afonso Adriano Jose Galimberti has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | SCL STEPAN CO | AGrant or award Performance Sharesderivative | +1,310 | $0.00 | $0 | 1,310 | Apr 15, 2026 |
| Apr 13, 2026 | SCL STEPAN CO | AGrant or award Restricted Stock Unitsderivative | +2,621 | $0.00 | $0 | 2,621 | Apr 15, 2026 |
| Apr 13, 2026 | SCL STEPAN CO | AGrant or award Stock Appreciation Rightderivative | +3,694 | $0.00 | $0 | 3,694 | Apr 15, 2026 |
Questions about Afonso Adriano Jose Galimberti
Answered from the filings on this page, as of the latest one.
Is Afonso Adriano Jose Galimberti buying or selling?
Afonso Adriano Jose Galimberti has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Afonso Adriano Jose Galimberti's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Afonso Adriano Jose Galimberti has 0.
Where does Afonso Adriano Jose Galimberti file Form 4?
Afonso Adriano Jose Galimberti has filed Form 4 at SCL (STEPAN CO) as VP and GM Surfactants NA. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.